申请人:Siegfried Aktiengesellschaft
公开号:US04115393A1
公开(公告)日:1978-09-19
Compounds of the formula ##STR1## WHEREIN R represents hydrogen, halogen, hydroxy or alkyl or alkoxy containing from 1 to 4 carbon atoms; X represents benzyl, benzyloxy or benzylthio, or benzyl, benzyloxy or benzylthio substituted by a said radical R; A.sup.1 and A.sup.2 which can be the same or different are hydrogen or alkyl radical containing up to 10 carbon atoms such that the total number of carbon atoms in A.sup.1 and A.sup.2 is not more than 10; n is an integer of from 1 to 3; m is 1 or 2; And pharmacologically acceptable salts thereof. These compounds have pharmaceutical utility by virtue of their ability to reduce the level of fatty substances in the blood.
化合物的公式为 ##STR1## 其中 R代表氢、卤素、羟基或含有1至4个碳原子的烷基或烷氧基;X代表苄基、苄氧基或苄硫基,或者被上述基团R取代的苄基、苄氧基或苄硫基;A.sup.1和A.sup.2可以相同或不同,是含有最多10个碳原子的氢或烷基基团,使得A.sup.1和A.sup.2中碳原子的总数不超过10;n为1至3的整数;m为1或2;以及其药学上可接受的盐。这些化合物具有药物学上的用途,因为它们能够降低血液中的脂质物水平。